Sarepta Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
SRPT on Nasdaq
Location
215 First Street, Suite 415, Cambridge, MA

Insiders trading volume in the past year

Sarepta Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard Barry Director $323M Mar 10, 2025
Douglas S. Ingram President & CEO, Director $31.4M Nov 3, 2023
Michael Chambers Director $29.5M +$4.96M +20.2% Mar 10, 2025
M. Kathleen Behrens Director $20.6M Mar 10, 2025
Louise Rodino-Klapac Head of R&D, CSO $10.5M Mar 7, 2025
Ian Estepan Chief Financial Officer $8.33M -$822K -8.99% Mar 7, 2025
Dallan Murray Chief Customer Officer $5.88M -$509K -7.96% Mar 7, 2025
Bilal Arif Chief Tech Ops Officer $5.31M -$1.92M -26.5% Mar 10, 2025
Ryan Brown EVP, General Counsel $2.82M -$6.3M -69.1% Jun 21, 2024
Claude Nicaise Director $2.77M -$248K -8.22% Mar 12, 2025
Hans Wigzell Director $2.53M -$1.31M -34.2% Mar 10, 2025
Cristin Rothfuss EVP, General Counsel $2.11M Mar 10, 2025
William Ciambrone Evp $1.78M Mar 4, 2022
Mary Ann Gray Director $993K Mar 7, 2022
Stephen Mayo Director $902K Mar 10, 2025
Kathryn Boor Director $827K -$205K -19.9% Mar 10, 2025
Deirdre P. Connelly Director $523K Mar 10, 2025

Recent Insider Transactions by Companies or Individuals for Sarepta Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.